Author Topic: (Abst.) Efficacy of rituximab in refractory RRMS  (Read 32 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8190
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Efficacy of rituximab in refractory RRMS
« on: May 04, 2018, 02:21:14 pm »

This French study concerns a group of RRMS patients who had continued to progress in spite of taking natalizumab (Tysabri), mitoxantrone (Novantrone) or fingolimod (Gilenya)  and who were given rituximab (Rituxan).

From PubMed, May 4, 2018:


https://www.ncbi.nlm.nih.gov/pubmed/29722639
MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
53 Views
Last post October 29, 2016, 06:34:51 am
by agate
0 Replies
34 Views
Last post November 17, 2017, 09:11:56 pm
by agate
0 Replies
47 Views
Last post December 19, 2017, 02:43:17 pm
by agate
0 Replies
53 Views
Last post February 12, 2018, 04:07:56 pm
by agate
0 Replies
46 Views
Last post July 26, 2018, 03:51:15 pm
by agate